International Journal of Infection

Published by: Kowsar

The Seroprevalence of Toxoplasma, Cytomegalovirus and Rubella Infections in Women with Abortion in Kurdistan Region of Iraq: A Brief Report

Nawfal Hussein 1 , * and Amer A Balatay 2
Authors Information
1 Department of Internal Medicine, College of Medicine, University of Duhok, Duhok, Iraq
2 College of Pharmacy, University of Duhok, Duhok, Iraq
Article information
  • International Journal of Infection: 6 (1); e86734
  • Published Online: January 19, 2019
  • Article Type: Brief Report
  • Received: November 24, 2018
  • Revised: January 4, 2019
  • Accepted: January 9, 2019
  • DOI: 10.5812/iji.86734

To Cite: Hussein N, Balatay A A. The Seroprevalence of Toxoplasma, Cytomegalovirus and Rubella Infections in Women with Abortion in Kurdistan Region of Iraq: A Brief Report, Int J Infect. Online ahead of Print ; 6(1):e86734. doi: 10.5812/iji.86734.

Abstract
Copyright © 2019, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94. doi: 10.1016/j.ijpara.2009.04.003. [PubMed: 19433092].
  • 2. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: A systematic review. Bull World Health Organ. 2013;91(7):501-8. doi: 10.2471/BLT.12.111732. [PubMed: 23825877]. [PubMed Central: PMC3699792].
  • 3. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102. doi: 10.1128/CMR.00062-12. [PubMed: 23297260]. [PubMed Central: PMC3553672].
  • 4. Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SG, Fakhrie-Kashan Z. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. Congenit Anom (Kyoto). 2016;56(2):73-8. doi: 10.1111/cga.12138. [PubMed: 26499091].
  • 5. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling. Lancet. 1999;353(9167):1829-33. doi: 10.1016/S0140-6736(98)08220-8. [PubMed: 10359407].
  • 6. Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, et al. Reducing the global burden of congenital rubella syndrome: Report of the World Health Organization Steering Committee on research related to measles and rubella vaccines and vaccination, June 2004. J Infect Dis. 2005;192(11):1890-7. doi: 10.1086/497607. [PubMed: 16267759].
  • 7. Ramana BV, Reddy BK, Murty DS, Vasudevanaidu KH. Seroprevalance of rubella in women with bad obstetric history. J Family Med Prim Care. 2013;2(1):44-6. doi: 10.4103/2249-4863.109943. [PubMed: 24479042]. [PubMed Central: PMC3894004].
  • 8. Malik A, Rizvi M, Khan F, Khan N, Rabbani T, Khan HM. Toxoplasma gondii in women with bad obstetric history and infertility: A five-year study. Asian Pac J Trop Dis. 2014;4:S236-9. doi: 10.1016/s2222-1808(14)60446-1.
  • 9. Ghasemi FS, Rasti S, Piroozmand A, Bandehpour M, Kazemi B, Mousavi SG, et al. Toxoplasmosis-associated abortion and stillbirth in Tehran, Iran. J Matern Fetal Neonatal Med. 2016;29(2):248-51. doi: 10.3109/14767058.2014.996127. [PubMed: 25564725].
  • 10. Flegr J, Prandota J, Sovickova M, Israili ZH. Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9(3). e90203. doi: 10.1371/journal.pone.0090203. [PubMed: 24662942]. [PubMed Central: PMC3963851].
  • 11. Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012;19(3):365-7. doi: 10.1128/CVI.05486-11. [PubMed: 22205659]. [PubMed Central: PMC3294603].
  • 12. Akyar I. Seroprevalence and coinfections of Toxoplasma gondii in childbearing age women in turkey. Iran J Public Health. 2011;40(1):63-7. [PubMed: 23113056]. [PubMed Central: PMC3481714].
  • 13. Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison's principles of internal medicine. New York, NY: McGraw-Hill; 2015.
  • 14. Wei HX, Wei SS, Lindsay DS, Peng HJ. A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans. PLoS One. 2015;10(9). e0138204. doi: 10.1371/journal.pone.0138204. [PubMed: 26394212]. [PubMed Central: PMC4578932].
  • 15. Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM seroprevalence among women of reproductive age in the United States. PLoS One. 2016;11(3). e0151996. doi: 10.1371/journal.pone.0151996. [PubMed: 26990759]. [PubMed Central: PMC4798411].
  • 16. Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: A retrospective cohort. Clin Infect Dis. 2013;56(10):1428-35. doi: 10.1093/cid/cit059. [PubMed: 23392397].
  • 17. Tan BH. Cytomegalovirus treatment. Curr Treat Options Infect Dis. 2014;6(3):256-70. doi: 10.1007/s40506-014-0021-5. [PubMed: 25999800]. [PubMed Central: PMC4431713].
  • 18. Pass RF, Arav-Boger R. Maternal and fetal cytomegalovirus infection: Diagnosis, management, and prevention. F1000Res. 2018;7:255. doi: 10.12688/f1000research.12517.1. [PubMed: 29560263]. [PubMed Central: PMC5832908].
  • 19. Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: Outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS One. 2013;8(1). e55043. doi: 10.1371/journal.pone.0055043. [PubMed: 23383049]. [PubMed Central: PMC3561451].
  • 20. Sasmaz T, Kurt AO, Ozturk C, Bugdayci R, Oner S. Rubella seroprevalence in women in the reproductive period, Mersin, Turkey. Vaccine. 2007;25(5):912-7. doi: 10.1016/j.vaccine.2006.09.033. [PubMed: 17049680].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments